Minted: - / 5000

1006 Omarigliptin
a5c762f8a61b1943b468a379f39ce75adef40f7e4d16ce4175658f7c8e817404

Properties

Background

Red
Bottle

Purple
Cap

Pink
Syringe

Green
Bubbles
No
Drops
No
Label
-

Chemistry

Formula
C17H20F2N4O3S
Carbon
17
Polarity
Neutral

Omarigliptin (MK-3102) is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co. It inhibits DPP-4 to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.

From Wikipedia, the free encyclopedia. License: CC BY-SA.